Hereditary Cancer Testing

Ensuring a healthy and successful pregnancy

What is Hereditary Cancer Testing

Hereditary cancers account for approximately 5-10% of all cancer cases. This type of cancer usually occurs as a result of the inheritance of a genetic variant from a parent.

Indicators for Hereditary cancer testing

  • Unaffected Patient 
  • Individual with a family history 
  • Any individual who would like to determine their risk 
  • Affected Patient 
  • Suspected case of hereditary cancer 
  • Diagnosed at an early age 
  • Presents with cancer in multiple sites

Benefits of hereditary cancer testing

Hereditary cancer testing can play a crucial role in personalized cancer risk assessment, early detection, prevention, treatment decision-making, and family planning, ultimately improving outcomes for individuals and their families at risk of hereditary cancer syndromes.

Why Viafet

Viafet’s tailored testing options, such as targeted mutation detection and next-generation sequencing using basic and extended panels, allow for comprehensive genetic testing for hereditary cancer syndromes based on clinical indications. 

The individualized precision medicine report provided by Viafet includes key information for each patient, such as the specific mutation(s) detected, their predisposition for developing cancer based on genetic findings, and the most beneficial targeted therapy options available. This personalized approach allows for tailored management and treatment strategies based on the patient’s unique genetic profile.

Viafet’s emphasis on providing diagnosis of inherited cancer and preventive strategies through clinical preimplantation genetic testing sets it apart as a unique laboratory in the field of hereditary cancer testing. Preimplantation genetic testing can help individuals at risk of hereditary cancer syndromes make informed decisions about family planning and potentially avoid passing on genetic mutations to future generations.